Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06291441
Other study ID # WUIPS
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 28, 2024
Est. completion date December 31, 2025

Study information

Verified date May 2024
Source IRCCS San Raffaele
Contact Sara Trapani
Phone 338 9879403
Email trapani.sara@hsr.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this multicenter prospective and prevalence observational study is to punctually investigate and describe prevalence, predictors, quality of life and costs of Urinary Incontinence (UI) among female patients, female caregivers and female personnel in four hospitals in Northern Italy: San Raffaele hospital in Milan, San Raffaele Turro hospital in Milan, Zingonia Policlinico San Marco (BG) and Policlinico San Pietro in Ponte San Pietro (BG).


Description:

EXPECTED RESULTS The collection of data and information through this study will aim to: 1. Understand the percentage of middle-aged women with UI. 2. Describe the socio-demographic and clinical characteristics of women with UI. 3. Identify UI predictors. 4. Describe the quality of life, social impact and costs of women with UI.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1842
Est. completion date December 31, 2025
Est. primary completion date June 28, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 65 Years
Eligibility INCLUSION CRITERIA - Female sex - Middle age (40-65 years old) - Informed consent signed - Comprehension of written and spoken Italian language - Female outpatients intended for any hospital unit (outpatient clinic, day surgery and day hospital patients included) and every female caregiver respecting the previous inclusion criteria, recruited at the central admission and at the private admission of the four hospitals involved - Female workers (healthcare professionals and administrative personnel) of the four hospitals EXCLUSION CRITERIA - Male sex - Young age (< 40 years) and older age (> 65 years) - Pregnant women - Puerperium women (up to 40 days post-partum) - Women who had undergone urinary and gynecology surgery

Study Design


Intervention

Other:
No intervention
No intervention (observational study)

Locations

Country Name City State
Italy Policlinico San Pietro Ponte San Pietro Bergamo
Italy San Raffaele Hospital (MI) Milan
Italy San Raffaele Turro Hospital (MI) Milan
Italy Policlinico San Marco Zingonia Osio Sotto Bergamo

Sponsors (2)

Lead Sponsor Collaborator
IRCCS San Raffaele Università Vita-Salute San Raffaele

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of middle-aged women with urinary incontinence Epidemiological data
Measure:
- Italian version of International Consultation of Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ UI-SF)
by December 2025
Secondary Predictors of urinary incontinence in middle-aged women Description and association between UI and related predictors
Measure:
- UI Survey: A part of the survey, written in Italian by the authors, will collect women's socio-demographic and clinical characteristics (predictors of UI)
by December 2025
Secondary Quality of life of middle-aged women with urinary incontinence Description and association between UI and quality of life
Measure:
- Italian version of Incontinence Impact Questionnaire-7 (IIQ-7) for investigating women's quality of life
by December 2025
Secondary Social impact of middle-aged women with urinary incontinence Description and association between UI and social impact
Measure:
- UI Survey: A part of the survey, written in Italian by the authors, will collect social impact of UI through a 4-point Likert scale
by December 2025
Secondary Costs of urinary incontinence for middle-aged women Description of UI costs
Measure:
- UI Survey: A part of the survey, written in Italian by the authors, will collect costs of UI through a 5-point Likert scale
by December 2025
See also
  Status Clinical Trial Phase
Completed NCT00270738 - Treatment for Female Stress Urinary Incontinence N/A